Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-823-1 | CAS number: 55514-22-2
Endpoint summary
Administrative data
Description of key information
Additional information
The only aquatic toxicity test performed was toxicity to microorganisms, as no water conscentration control is required. This test lead to the conclusion that no toxicity was observed in a limit test at 100 mg/L nominal concentration of WP30.
Other tests were waived because scientifically injustified, for the following reasons:
1. WP30 solubility limit was measured to be < 0.020 µg/L (limit of detection). Therefore no valid test could be conducted with a water solubility limit that cannot be measured.
2. A weight of evidence approach allows concluding that WP30 is not absorbed in living cells, relying on following observations
a. Chronic toxicity studies with mammals
a.1.Combined repeated dose and reproduction / developmental screening (oral: gavage) on WP30
This validity 1 study concluded to aNOEL: > 1000 mg/kg bw/day (actual dose received) (male/female) based on test material (No effect observed) after ca. 50 days.
b. Toxicokinetic studies with mammals
b.1.Combined repeated dose and reproduction / developmental screening (oral: gavage) on WP30 : ADME results
WP30 absorption was checked. No significant systemic exposure to the test item was measured throughout 5 weeks, up to 1000 mg/kg/d.
Therefore no bioaccumulation potential was observed based on these study results.
b.2. In vitro skin penetration of WP30 (Human skin)
The mean absorption of applied WP30 on Human skin samples was 0.17 +/- 0.32 % (2 SD) according to SCCS/1358/10 guidance. This means that there is no WP30 absorption through Human skin.
b.3.In vitro skin penetration of WP30 (altered Human skin) (OECD 428)
In vitro absorption through Human skin has been determined according to OECD guidelie 428, on untreated skin, irradiated (UVA and UVB) skin, and tape-stripped and irradiated skin. Absorption was found to be negligible in all conditions.
b.4 Summary
Evidence of lack of absorption of WP30 has been shown in several excised skin permeation models, and mammalian toxicity studies performed, up to 5 weeks daily repeated ingestion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
